Oracle (NYSE:ORCL – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at JMP Securities in a report issued on Tuesday,Benzinga reports. They presently have a $205.00 price target on the enterprise software provider’s stock. JMP Securities’ target price suggests a potential upside of 15.56% from the company’s current price.
ORCL has been the subject of a number of other research reports. Sanford C. Bernstein upped their price objective on Oracle from $201.00 to $202.00 and gave the stock an “outperform” rating in a research note on Monday, September 30th. Oppenheimer reiterated a “market perform” rating on shares of Oracle in a research report on Tuesday, September 10th. Melius Research upgraded Oracle from a “hold” rating to a “buy” rating in a report on Monday, September 16th. TD Cowen increased their target price on shares of Oracle from $165.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, September 10th. Finally, Mizuho lifted their price target on Oracle from $185.00 to $210.00 and gave the company an “outperform” rating in a report on Tuesday. Eleven research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $178.60.
Read Our Latest Stock Analysis on ORCL
Oracle Stock Performance
Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings results on Monday, December 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.06 billion for the quarter, compared to analysts’ expectations of $14.12 billion. Oracle had a net margin of 20.40% and a return on equity of 171.38%. Oracle’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.34 EPS. Equities analysts anticipate that Oracle will post 5.06 earnings per share for the current year.
Insider Activity at Oracle
In other news, EVP Maria Smith sold 6,320 shares of the company’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $165.00, for a total transaction of $1,042,800.00. Following the completion of the transaction, the executive vice president now directly owns 42,889 shares of the company’s stock, valued at $7,076,685. This represents a 12.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 42.20% of the stock is owned by company insiders.
Institutional Investors Weigh In On Oracle
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fairway Wealth LLC purchased a new position in shares of Oracle in the second quarter valued at approximately $27,000. POM Investment Strategies LLC purchased a new position in Oracle in the 2nd quarter valued at $30,000. Quest Partners LLC acquired a new stake in Oracle during the 2nd quarter worth $40,000. Reston Wealth Management LLC purchased a new stake in shares of Oracle during the third quarter worth $44,000. Finally, Avondale Wealth Management acquired a new stake in shares of Oracle in the third quarter valued at about $51,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- Manufacturing Stocks Investing
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to Most Effectively Use the MarketBeat Earnings Screener
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
- How to Calculate Inflation Rate
- Tesla’s Closes in on $400: From Laggard to Leader in 2024
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.